SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMP -- Ignore unavailable to you. Want to Upgrade?

To: M. Frank Greiffenstein who wrote (365)4/15/1998 7:11:00 AM
From: Emec  Respond to of 1308
 
Press release out-a bit confusing. Says .29 per share but when look at income statement it is .27 fully diluted. However, comparing to last quarter, it appears that .20 was not diluted so perhaps a true comparison is .27 v. .18? In any event, what is critical to note here and what I have tried to tell everyone is that earnings will go up faster than revenue with CMP. Revenues up 25%, earnings up either 35% or 45% depending what you compare it to.



To: M. Frank Greiffenstein who wrote (365)4/15/1998 8:03:00 AM
From: Linda Kaplan  Read Replies (1) | Respond to of 1308
 
Hi,

I have to disagree with the "piddly contract" comments you've been making. Look at the annual earnings and the float. Can't you see that a $300,000 contract is a very significant contract to a company this size, and that it would affect the earnings greatly?

I'm no cheerleader, but they only made $1 million this quarter, so if you add another $300 thousand, that's a big percentage increase, isn't it?

Linda


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News